RESUMEN

PURPOSE: Rhinoviruses (RVs) occur more frequently than other viruses and more often in people displaying symptoms than in those without. We sought to estimate the spectrum of RV diversity, RV species seasonality and to analyse RV involvement in respiratory virus co-detections. METHODOLOGY: A convenience collection of 1179 airway sample extracts from patients with suspected respiratory infections, collected during 2001, was subjected to comprehensive molecular testing. RESULTS: RVs were the most common virus detected. We were able to genotype ~90 % of RV detections, identifying 70 distinct RVs, spanning all three species. RV-Bs were under-represented. We found RV species co-circulated at times, although one species usually dominated. Each species displayed a bimodal distribution. CONCLUSION: Notably, RVs and influenza A viruses (IFAV) seldom co-occurred, supporting their roles as primary pathogens of the airway among acutely ill infants. Whether RV circulation has a moderating or controlling effect on the IFAV season or is controlled by it cannot be determined from these data. Despite the frequent perception that RVs commonly co-occur with another virus, our findings indicated this was not always the case. Nearly 80 % of RV detections occurred alone. Understanding more about population-level interference between viruses may allow us to harness aspects of it to generate a non-specific antiviral intervention that mimics a putative protective effect. For routine respiratory virus screening to best serve the patient, RV testing should be a principal component of any acute respiratory illness testing algorithm throughout the year.

RESUMEN

BACKGROUND: Parechoviruses (HPeV) are endemic seasonal pathogens detected from the respiratory tract, gut, blood and central nervous system (CNS) of children and adults, sometimes in conjunction with a range of acute illnesses. HPeV CNS infection may lead to neurodevelopmental sequelae, especially following infection by HPeV-3, hence screening and genotyping are important to inform epidemiology, aetiology and prognosis. OBJECTIVES: To identify and characterise HPeVs circulating during an outbreak between November 2013 and April 2014 in Queensland, Australia. STUDY DESIGN: To perform PCR-based screening and comparative nucleotide sequence analysis on samples from children with clinically suspected infections submitted to a research laboratory for HPeV investigations. RESULTS: HPeVs were detected among 25/62 samples, identified as HPeV-3 from 23 that could be genotyped. These variants closely matched those which have occurred worldwide and in other States of Australia. CONCLUSIONS: The inclusion of PCR-based HPeV testing is not systematically applied but should be considered essential for children under 3 months of age with CNS symptoms as should long-term follow-up of severe sepsis-like cases.

Asunto(s)

Brotes de Enfermedades , Genotipo , Parechovirus/clasificación , Parechovirus/aislamiento & purificación , Infecciones por Picornaviridae/epidemiología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Parechovirus/genética , Infecciones por Picornaviridae/virología , Reacción en Cadena de la Polimerasa , Queensland/epidemiología , Análisis de Secuencia de ADN

RESUMEN

The human coronaviruses (CoV) include HCoV-229E, HCoV-OC43, HCoV-NL63, and HCoV-HKU1, some of which have been known for decades. The severe acute respiratory syndrome (SARS) CoV briefly emerged into the human population but was controlled. In 2012, another novel severely human pathogenic CoV-the Middle East Respiratory Syndrome (MERS)-CoV-was identified in the Kingdom of Saudi Arabia; 80% of over 2000 human cases have been recorded over five years. Targeted research remains key to developing control strategies for MERS-CoV, a cause of mild illness in its camel reservoir. A new therapeutic toolbox being developed in response to MERS is also teaching us more about how CoVs cause disease. Travel-related cases continue to challenge the world's surveillance and response capabilities, and more data are needed to understand unexplained primary transmission. Signs of genetic change have been recorded, but it remains unclear whether there is any impact on clinical disease. How camels came to carry the virus remains academic to the control of MERS. To date, human-to-human transmission has been inefficient, but virus surveillance, characterisation, and reporting are key to responding to any future change. MERS-CoV is not currently a pandemic threat; it is spread mainly with the aid of human habit and error.

Asunto(s)

Infecciones por Coronavirus/veterinaria , Infecciones por Coronavirus/virología , Coronavirus del Síndrome Respiratorio de Oriente Medio/patogenicidad , Zoonosis/virología , Animales , Camelus , Enfermedades Transmisibles Importadas/epidemiología , Enfermedades Transmisibles Importadas/virología , Infecciones por Coronavirus/epidemiología , Reservorios de Enfermedades , Monitoreo Epidemiológico , Humanos , Arabia Saudita , Viaje , Zoonosis/epidemiología

RESUMEN

Toscana virus (TOSV) is identified in sandflies, animals, and humans around the Mediterranean Sea. TOSV has not been reported in Australia. During investigations of cerebrospinal fluid samples from patients with encephalitis, TOSV genetic sequences were identified in a traveler returning to Australia from Europe. TOSV should be considered, especially during May to October, in travelers to Australia who embarked in countries in and around the Mediterranean Sea and who subsequently present for medical care because of neurological symptoms.

Asunto(s)

Encefalitis Viral/diagnóstico , Fiebre por Flebótomos/diagnóstico , Virus de Nápoles de la Fiebre de la Mosca de los Arenales/aislamiento & purificación , Enfermedad Relacionada con los Viajes , Animales , Anticuerpos Antivirales/sangre , Encefalitis Viral/líquido cefalorraquídeo , Encefalitis Viral/virología , Europa (Continente) , Humanos , Insectos Vectores/virología , Persona de Mediana Edad , Fiebre por Flebótomos/líquido cefalorraquídeo , Fiebre por Flebótomos/virología , Psychodidae/virología , Estudios Retrospectivos , Virus de Nápoles de la Fiebre de la Mosca de los Arenales/genética , Análisis de Secuencia de ADN

RESUMEN

Mayaro virus (MAYV) is an emerging arthropod-borne virus (arbovirus). Infection by MAYV can produce Mayaro virus disease (MAYVD) which is usually a clinically diagnosed, acute, febrile illness associated with prolonged and painful joint inflammation and swelling. MAYVD may be clinically indistinguishable from dengue, chikungunya fever, malaria, rabies, measles or other arboviral diseases. The full spectrum of disease, sequelae, routes of infection, virus shedding and any rarer means of transmission remain undefined. MAYVD cases in humans have so far been localised to Central and South America, particularly regions in and around the Amazon basin. MAYV usually circulates in a sylvan cycle of forest mosquitoes and vertebrates, however it has also been found in more urban locations alongside anthropophilic (preferring humans) insect vectors. If transmission via anthropophilic mosquitoes becomes more efficient following viral change, or existing vectors change their habitat and biting habits, the risk of urban establishment and further spread into non-forested areas will grow. Surveillance, testing and vector control remain key to monitoring and preventing global spread and establishment. The possibility of MAYV becoming further urbanized is worthy of note, consideration and action to ensure MAYV does not spread beyond the forests and establish in the world's cities.

Asunto(s)

Infecciones por Alphavirus/epidemiología , Infecciones por Alphavirus/virología , Alphavirus/fisiología , Alphavirus/patogenicidad , Enfermedades Transmisibles Emergentes/epidemiología , Enfermedades Transmisibles Emergentes/virología , Infecciones por Alphavirus/patología , Infecciones por Alphavirus/transmisión , Animales , América Central/epidemiología , Enfermedades Transmisibles Emergentes/patología , Enfermedades Transmisibles Emergentes/transmisión , Culicidae/virología , Transmisión de Enfermedad Infecciosa , Vectores de Enfermedades , Humanos , Insectos Vectores , Control de Mosquitos , América del Sur/epidemiología , Población Urbana

RESUMEN

The first known cases of Middle East respiratory syndrome (MERS), associated with infection by a novel coronavirus (CoV), occurred in 2012 in Jordan but were reported retrospectively. The case first to be publicly reported was from Jeddah, in the Kingdom of Saudi Arabia (KSA). Since then, MERS-CoV sequences have been found in a bat and in many dromedary camels (DC). MERS-CoV is enzootic in DC across the Arabian Peninsula and in parts of Africa, causing mild upper respiratory tract illness in its camel reservoir and sporadic, but relatively rare human infections. Precisely how virus transmits to humans remains unknown but close and lengthy exposure appears to be a requirement. The KSA is the focal point of MERS, with the majority of human cases. In humans, MERS is mostly known as a lower respiratory tract (LRT) disease involving fever, cough, breathing difficulties and pneumonia that may progress to acute respiratory distress syndrome, multiorgan failure and death in 20% to 40% of those infected. However, MERS-CoV has also been detected in mild and influenza-like illnesses and in those with no signs or symptoms. Older males most obviously suffer severe disease and MERS patients often have comorbidities. Compared to severe acute respiratory syndrome (SARS), another sometimes- fatal zoonotic coronavirus disease that has since disappeared, MERS progresses more rapidly to respiratory failure and acute kidney injury (it also has an affinity for growth in kidney cells under laboratory conditions), is more frequently reported in patients with underlying disease and is more often fatal. Most human cases of MERS have been linked to lapses in infection prevention and control (IPC) in healthcare settings, with approximately 20% of all virus detections reported among healthcare workers (HCWs) and higher exposures in those with occupations that bring them into close contact with camels. Sero-surveys have found widespread evidence of past infection in adult camels and limited past exposure among humans. Sensitive, validated reverse transcriptase real-time polymerase chain reaction (RT-rtPCR)-based diagnostics have been available almost from the start of the emergence of MERS. While the basic virology of MERS-CoV has advanced over the past three years, understanding of the interplay between camel, environment, and human remains limited.

Asunto(s)

Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/veterinaria , Infección Hospitalaria/transmisión , Transmisión de Enfermedad Infecciosa , Coronavirus del Síndrome Respiratorio de Oriente Medio/aislamiento & purificación , Zoonosis/transmisión , Animales , Camelus , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/transmisión , Salud Global , Humanos , Técnicas de Diagnóstico Molecular/métodos , Exposición Profesional , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos

Asunto(s)

Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/transmisión , Transmisión de Enfermedad Infecciosa , Coronavirus del Síndrome Respiratorio de Oriente Medio/aislamiento & purificación , Animales , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/patología , Humanos

RESUMEN

In 2012 in Jordan, infection by a novel coronavirus (CoV) caused the first known cases of Middle East respiratory syndrome (MERS). MERS-CoV sequences have since been found in a bat and the virus appears to be enzootic among dromedary camels across the Arabian Peninsula and in parts of Africa. The majority of human cases have occurred in the Kingdom of Saudi Arabia (KSA). In humans, the etiologic agent, MERS-CoV, has been detected in severe, mild and influenza-like illness and in those without any obvious signs or symptoms of disease. MERS is often a lower respiratory tract disease associated with fever, cough, breathing difficulties, pneumonia that can progress to acute respiratory distress syndrome, multiorgan failure and death among more than a third of those infected. Severe disease is usually found in older males and comorbidities are frequently present in cases of MERS. Compared to SARS, MERS progresses more rapidly to respiratory failure and acute kidney injury, is more often observed as severe disease in patients with underlying illnesses and is more often fatal. MERS-CoV has a broader tropism than SARS-CoV, rapidly triggers cellular damage, employs a different receptor and induces a delayed proinflammatory response in cells. Most human cases have been linked to lapses in infection prevention and control in healthcare settings, with a fifth of virus detections reported among healthcare workers. This review sets out what is currently known about MERS and the MERS-CoV, summarises the new phenomenon of crowd-sourced epidemiology and lists some of the many questions that remain unanswered, nearly three years after the first reported case.

Asunto(s)

Enfermedades Transmisibles Emergentes/epidemiología , Infecciones por Coronavirus/epidemiología , Zoonosis/epidemiología , África/epidemiología , Animales , Arabia/epidemiología , Camelus , Quirópteros , Enfermedades Transmisibles Emergentes/patología , Enfermedades Transmisibles Emergentes/virología , Infecciones por Coronavirus/patología , Infecciones por Coronavirus/virología , Humanos , Coronavirus del Síndrome Respiratorio de Oriente Medio/aislamiento & purificación , Zoonosis/patología , Zoonosis/virología

Asunto(s)

Convalecencia , Ebolavirus/aislamiento & purificación , Fiebre Hemorrágica Ebola/virología , Semen/virología , Adulto , Humanos , Masculino , ARN Viral/aislamiento & purificación , Factores de Tiempo

Asunto(s)

Brotes de Enfermedades , Subtipo H7N9 del Virus de la Influenza A/aislamiento & purificación , Gripe Humana/epidemiología , Gripe Humana/virología , Enfermedades Asintomáticas/epidemiología , Preescolar , Humanos , Incidencia , Gripe Humana/mortalidad , Gripe Humana/patología , Análisis de Supervivencia

RESUMEN

Human rhinovirus (HRV) replication triggers exacerbation of asthma and causes most acute respiratory illnesses (ARIs), which may manifest as influenza-like illness. The recent assignment of 60 previously unknown HRV types to a third HRV species, Human rhinovirus C, raised questions about the prevalence of these picornavirus types in the community, the extent of HRV diversity at a single site, and whether the HRVs have an equally diverse clinical impact on their hosts. We quantified HRV diversity, and there was no clinical impact attributable to HRV species and genotypes among a community population of preschool-aged children with ARI who provided respiratory samples during 2003. All HRV species were represented among 138 children with ARI, and 74 distinct HRV types were cocirculating. Fever accompanied 32.8% of HRV-positive ARI cases. HRVs were less likely than DNA viruses to be codetected with another virus, suggesting virus interference at the community level, demonstrated by the inverse correlation between influenza virus detection and HRV detection.

Asunto(s)

Portador Sano/epidemiología , Infecciones por Picornaviridae/epidemiología , Infecciones del Sistema Respiratorio/epidemiología , Rhinovirus/aislamiento & purificación , Australia/epidemiología , Portador Sano/virología , Preescolar , Estudios de Cohortes , Femenino , Variación Genética , Genotipo , Humanos , Lactante , Masculino , Infecciones por Picornaviridae/virología , Prevalencia , Infecciones del Sistema Respiratorio/virología , Rhinovirus/clasificación , Rhinovirus/genética

RESUMEN

Acute respiratory illnesses (ARIs) with unconfirmed infectious aetiologies peak at different times of the year. Molecular diagnostic assays reduce the number of unconfirmed ARIs compared to serology- or culture-based techniques. Screening of 888 inpatient and outpatient respiratory specimens spanning late autumn through to early spring, 2004, identified the presence of a human coronavirus (HCoV) on 74 occasions (8.3% of all specimens and 26.3% of all respiratory virus detections). Prevalence peaked in August (late winter in the southern hemisphere) when they were detected in 21.9% of specimens tested. HCoV-HKU1 and HCoV-OC43 comprised 82.4% of all HCoVs detected. Positive specimens were used to develop novel reverse transcriptase real-time PCRs (RT-rtPCRs) for HCoV detection. An objective clinical severity score was assigned to each positive HCoV patient. Severity scores were similar to those from a random selection of young children who were positive for respiratory syncytial virus at a different time but from the same specimen population. During the cooler months of 2004, sensitive and specific RT-rtPCRs identified the concurrent circulation of all four HCoVs, a quarter of which co-occurred with another virus and most of which were from children under the age of two years.

Asunto(s)

Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/virología , Coronavirus/clasificación , Coronavirus/aislamiento & purificación , Infecciones del Sistema Respiratorio/epidemiología , Infecciones del Sistema Respiratorio/virología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Técnicas de Laboratorio Clínico/métodos , Infecciones por Coronavirus/patología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Prevalencia , Queensland/epidemiología , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Estudios Retrospectivos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Estaciones del Año , Sensibilidad y Especificidad , Análisis de Secuencia de ADN , Índice de Severidad de la Enfermedad , Virología/métodos , Adulto Joven

RESUMEN

We conducted a preliminary comparison of the relative sensitivity of a cross-section of published human rhinovirus (HRV)-specific PCR primer pairs, varying the oligonucleotides and annealing temperature. None of the pairs could detect all HRVs in 2 panels of genotyped clinical specimens; >1 PCR is required for accurate description of HRV epidemiology.

Asunto(s)

Cartilla de ADN , Infecciones por Picornaviridae/diagnóstico , Reacción en Cadena de la Polimerasa/métodos , Rhinovirus/aislamiento & purificación , Cartilla de ADN/genética , Humanos , Infecciones por Picornaviridae/epidemiología , Infecciones por Picornaviridae/virología , ARN Viral/genética , Rhinovirus/clasificación , Rhinovirus/genética , Sensibilidad y Especificidad , Especificidad de la Especie

RESUMEN

There are few data describing the comprehensive identification in and influence of newly identified respiratory viruses on asthma exacerbations. Most studies focus on inpatients. In this preliminary study, the point prevalence and the associations of picornavirus species described recently and human bocavirus (HBoV) with the recovery from exacerbations in non-hospitalized asthmatic children (median age 5.1 years) were examined. Human rhinoviruses (HRVs) were present in 52.6% of specimens, HBoV-1 was in 7.7%. Viral co-detections occurred in 25.6% of children and were associated (P = 0.04) with lower asthma quality of life scores upon presentation than were single viral detections. The undifferentiated presence or absence of virus did not influence the severity of asthma or recovery however when virus species were examined individually, specific clinical associations emerged. HRV species C (HRV-Cs) were the viruses most frequently detected as single virus detections. Among 41 genotyped HRVs, more HRV-Cs (n = 23) were identified than HRV-As (n = 16) however HRV-A detection was associated (P = 0.01) with worse asthma symptoms and cough for longer than was HRV-C detection. Larger, PCR-based studies are required to elucidate further the true impact of HRV species in childhood asthma exacerbations of both hospitalized and non-hospitalized cohorts.

Asunto(s)

Asma/virología , Bocavirus Humano/aislamiento & purificación , Infecciones por Parvoviridae/epidemiología , Infecciones por Picornaviridae/epidemiología , Rhinovirus/aislamiento & purificación , Asma/patología , Niño , Preescolar , Comorbilidad , Genotipo , Hospitalización , Bocavirus Humano/clasificación , Bocavirus Humano/genética , Humanos , Infecciones por Parvoviridae/virología , Infecciones por Picornaviridae/virología , Prevalencia , ARN Viral/genética , Rhinovirus/clasificación , Rhinovirus/genética

RESUMEN

Human rhinovirus (HRV) infections cause at least 70% of virus-related wheezing exacerbations and cold and flu-like illnesses. They are associated with otitis media, sinusitis and pneumonia. Annually, the economic impact of HRV infections costs billions in healthcare and lost productivity. Since 1987, 100 officially recognised HRV serotypes reside in two genetically distinct species; HRV A and HRV B, within the genus Enterovirus, family Picornaviridae. Sequencing of their approximately 7kb genomes was finalised in 2009. Since 1999, many globally circulating, molecularly-defined 'strains', perhaps equivalent to novel serotypes, have been discovered but remain uncharacterised. Many of these currently unculturable strains have been assigned to a proposed new species, HRV C although confusion exists over the membership of the species. There has not been sufficient sampling to ensure the identification of all strains and no consensus criteria exist to define whether clinical HRV detections are best described as a distinct strain or a closely related variant of a previously identified strain (or serotype). We cannot yet robustly identify patterns in the circulation of newly identified HRVs (niHRVs) or the full range of associated illnesses and more data are required. Many questions arise from this new found diversity: what drives the development of so many distinct viruses compared to other species of RNA viruses? What role does recombination play in generating this diversity? Are there species- or strain-specific circulation patterns and clinical outcomes? Are divergent strains sensitive to existing capsid-binding antivirals? This update reviews the findings that trigger these and other questions arising during the current cycle of intense rhinovirus discovery.

Asunto(s)

Resfriado Común/epidemiología , Resfriado Común/virología , Polimorfismo Genético , Rhinovirus/clasificación , Rhinovirus/genética , Resfriado Común/patología , Evolución Molecular , Humanos , Epidemiología Molecular , Recombinación Genética , Rhinovirus/aislamiento & purificación

RESUMEN

Rhinovirus infections cause at least 70% of virus-related wheezing exacerbations and cold and flu-like illnesses. Infections are also associated with otitis media, sinusitis and pneumonia. The annual impact of human rhinovirus (HRV) infections costs billions of healthcare dollars. To date, 100 serotyped HRV or 'classical' strains have been divided between two genetically distinct species based on subgenomic sequences, but many more, apparently novel strains remain un-characterized, circulating in unknown patterns and causing undefined illnesses. Until recently, the genomes of less than half the classical strains had been sequenced. In April 2009, the remaining classical HRV genome sequences were reported. These data will inform therapeutic development and phylogenetic analysis for this subset of HRV strains but should be viewed as one step in a long road leading to comprehensive HRV characterization.

Asunto(s)

Enfermedades Transmisibles Emergentes/virología , Infecciones por Picornaviridae/virología , Rhinovirus/clasificación , Australia/epidemiología , Enfermedades Transmisibles Emergentes/epidemiología , Brotes de Enfermedades , Humanos , New York/epidemiología , Infecciones por Picornaviridae/epidemiología , Rhinovirus/aislamiento & purificación

RESUMEN

Viruses are the major cause of pediatric acute respiratory tract infection (ARTI) and yet many suspected cases of infection remain uncharacterized. We employed 17 PCR assays and retrospectively screened 315 specimens selected by season from a predominantly pediatric hospital-based population. Before the Brisbane respiratory virus research study commenced, one or more predominantly viral pathogens had been detected in 15.2% (n = 48) of all specimens. The Brisbane study made an additional 206 viral detections, resulting in the identification of a microbe in 67.0% of specimens. After our study, the majority of microbes detected were RNA viruses (89.9%). Overall, human rhinoviruses (HRVs) were the most frequently identified target (n = 140) followed by human adenoviruses (HAdVs; n = 25), human metapneumovirus (HMPV; n = 18), human bocavirus (HBoV; n = 15), human respiratory syncytial virus (HRSV; n = 12), human coronaviruses (HCoVs; n = 11), and human herpesvirus-6 (n = 11). HRVs were the sole microbe detected in 37.8% (n = 31) of patients with suspected lower respiratory tract infection (LRTI). Genotyping of the HRV VP4/VP2 region resulted in a proposed subdivision of HRV type A into sublineages A1 and A2. Most of the genotyped HAdV strains were found to be type C. This study describes the high microbial burden imposed by HRVs, HMPV, HRSV, HCoVs, and the newly identified virus, HBoV on a predominantly paediatric hospital population with suspected acute respiratory tract infections and proposes a new formulation of viral targets for future diagnostic research studies.

Asunto(s)

Infecciones por Coronavirus/epidemiología , Coronavirus/aislamiento & purificación , Infecciones por Paramyxoviridae/epidemiología , Paramyxoviridae/aislamiento & purificación , Infecciones por Parvoviridae/epidemiología , Infecciones por Picornaviridae/epidemiología , Infecciones del Sistema Respiratorio/epidemiología , Rhinovirus/aislamiento & purificación , Enfermedad Aguda , Adenoviridae/clasificación , Adenoviridae/genética , Adenoviridae/aislamiento & purificación , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Australia/epidemiología , Niño , Preescolar , Coronavirus/genética , Infecciones por Coronavirus/diagnóstico , Hospitales , Humanos , Lactante , Recién Nacido , Persona de Mediana Edad , Paramyxoviridae/genética , Infecciones por Paramyxoviridae/diagnóstico , Parvoviridae/genética , Infecciones por Parvoviridae/diagnóstico , Filogenia , Infecciones por Picornaviridae/diagnóstico , Infecciones del Sistema Respiratorio/diagnóstico , Infecciones del Sistema Respiratorio/virología , Estudios Retrospectivos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Rhinovirus/clasificación , Rhinovirus/genética , Estaciones del Año , Especificidad de la Especie

RESUMEN

The molecular epidemiologic profile of human metapneumovirus (hMPV) infection has likely been skewed toward certain genetic subtypes because of assay-design issues, and no comprehensive studies have been conducted to date. Here, reverse-transcription polymerase chain reaction was used to screen 10,319 specimens from patients presenting to hospitals with suspected respiratory tract infections during 2001-2004. After analysis of 727 Australian hMPV strains, 640 were assigned to 1 of 4 previously described subtypes. hMPV was the most common pathogen detected, and subtype B1 was the most common lineage. Concurrent, annual circulation of all 4 hMPV subtypes in our study population was common, with a single, usually different hMPV subtype predominating in each year.

Asunto(s)

Variación Genética , Metapneumovirus/clasificación , Metapneumovirus/genética , Infecciones por Paramyxoviridae/virología , ARN Viral/genética , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Australia/epidemiología , Niño , Preescolar , Femenino , Genes Virales , Genotipo , Humanos , Lactante , Recién Nacido , Masculino , Metapneumovirus/aislamiento & purificación , Persona de Mediana Edad , Epidemiología Molecular , Datos de Secuencia Molecular , Infecciones por Paramyxoviridae/epidemiología , Filogenia , Infecciones del Sistema Respiratorio/epidemiología , Infecciones del Sistema Respiratorio/virología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Análisis de Secuencia de ADN

RESUMEN

Undiagnosed cases of respiratory tract disease suspected of an infectious aetiology peak during the winter months. Since studies applying molecular diagnostic assays usually report reductions in the number of undiagnosed cases of infectious disease compared to traditional techniques, we applied PCR assays to investigate the role of two recently described viruses, namely human coronavirus (HCoV) HKU1 and human bocavirus (HBoV), in a hospital-based paediatric population. Both viruses were found among Australia children with upper or lower respiratory tract disease during the autumn and winter of 2004, contributing to 21.1% of all microbial diagnoses, with individual incidences of 3.1% (HCoV-HKU1) and 5.6% (HBoV) among 324 specimens. HBoV was found to coincide with another virus in more than half of all instances and displayed a single genetic lineage, whilst HCoV-HKU1 was more likely to occur in the absence of another microbe and strains could be divided into two genetic lineages which we propose be termed HCoV-HKU1 type A and type B. Children under the age of 2 years were most at risk of infection by these viruses which contribute significantly to the microbial burden among patients with respiratory tract disease during the colder months.

Asunto(s)

Infecciones por Coronavirus/epidemiología , Coronavirus/aislamiento & purificación , Infecciones por Parvoviridae/epidemiología , Parvovirinae/aislamiento & purificación , Infecciones del Sistema Respiratorio/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Australia/epidemiología , Niño , Preescolar , Coronavirus/genética , Infecciones por Coronavirus/virología , Femenino , Hospitalización , Humanos , Incidencia , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Infecciones por Parvoviridae/virología , Parvovirinae/genética , Reacción en Cadena de la Polimerasa , Infecciones del Sistema Respiratorio/virología , Estaciones del Año , Análisis de Secuencia de ADN